Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS

Neurology

Volumn 72, Issue 22, 2009, Pages 1948-1952

  Gordon, P H ^a,b   Cheng, B ^a   Katz, I B ^a   Mitsumoto, H ^a   Rowland, L P ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DYSPHAGIA; HUMAN; HYPOREFLEXIA; MOTONEURON; MUSCLE ATROPHY; MUSCLE STRENGTH; MUSCLE WEAKNESS; PRIMARY LATERAL SCLEROSIS; PRIORITY JOURNAL; RATING SCALE; VITAL CAPACITY; WEIGHT REDUCTION;

EID: 67650076729     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181a8269b     Document Type: Article

References (20)

1. Mitsumoto H, Chad D, Pioro EP. History, terminology and classification of ALS. In: Mitsumoto H, Chad D, Pioro EP, eds. Amyotrophic Lateral Sclerosis. Philadelphia: FA Davis; 1998;3-11.
2. Gordon PH, Cheng B, Katz IB, et al. The natural history of primary lateral sclerosis. Neurology 2006;66:647-653.
3. Rowland LP. Primary lateral sclerosis, hereditary spastic paraplegia, and mutations in the alsin gene: historical background for the first international conference on primary lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2005;6:67-76.
4. Brooks BR, Miller RG, Swash M, Munsat TL, for the World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;557-560.
5. A Controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (phase III). Neurology 1999;52:1427-1433.
6. Cedarbaum JM, Stambler N, Malta E, et al. The ALS- FRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function: BDNF ALS Study Group (phase II/III). J Neurol Sci 1999;169:13-21.
7. Great Lakes ALS Study Group. A comparison of muscle strength testing techniques in amyotrophic lateral sclerosis. Neurology2003;61:1503-1507.
8. Younger DS, Chou S, Hays AP, et al. Primary lateral sclerosis: a clinical diagnosis reemerges. Arch Neurol 1988;45:1304-1307.
9. Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis: clinical features, neuropathology and diagnostic criteria. Brain 1992;115:495-520.
10. Le Forestier N, Maisonobe T, Piquard A, et al. Does primary lateral sclerosis exist? A study of 20 patients and are view of the literature. Brain 2001;124:1989-1999.
11. Tartaglia MC, Rowe A, Findlater K, Orange JB, Grace G, Strong MJ. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination ofsymp- toms and signs at disease onset and during follow-up. Arch Neurol 2007;64:232-236.
12. Bruyn RP, Koelman JH, Troost D, de Jong JM. Motor neuron disease (amyotrophic lateral sclerosis) arising from longstanding primary lateral sclerosis. J Neurol Neurosurg Psychiatry 1995;58:742-744.
13. Singer MA, Statland JM, Wolfe GI, Barohn RJ. Primary lateral sclerosis. Muscle Nerve 2007;35:291-302.
14. Dupuis L, Corcia P, Fergani A, et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurol- ogy2008;70:1004-1009.
15. Leigh PN, Anderton BH, Dodson A, Gallo JM, Swash M,Power DM. Ubiquitin deposits in anterior horn cells in motor neurone disease. Neurosci Lett 1988;93:197-203.
16. Lowe J, Lennox G, Jefferson D, et al. A filamentous inclusion body within anterior horn neurons in motor neuron disease defined by immunocytochemical localization of ubiquitin. Neurosci Lett 1988;93:203-210.
17. Kato T, Katagiri T, Hirano A, Kawanami T, Sasaki H. Lewy body-like hyaline inclusions in sporadic motor neuron disease are ubiquitinated. Acta Neuropathol 1988;77:391-396.
18. Bunina TL. On intracellular inclusion in familial amyotro- phic lateral sclerosis [in Russian]. Korsakov J Neuropathol Psychiatry 1962;62:1293-1299.
19. Hart MN, Cancilla PA, Frommes S, Hirano A. Anterior horn cell degeneration and Bunina-type inclusions associated with dementia. Acta Neuropathol 1977;38:225-228.
20. Hirano A, Inoue K. Early pathological changes of amyo- trophic lateral sclerosis: electron microscopic study of chromatolysis, spheroids, and Bunina bodies. Neurol Med (Tokyo) 1980;13:148-160.